Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots

Journal of Medical Virology

Volumn 85, Issue 2, 2013, Pages 315-319

  Rajasekariah, Harshita ^a   Scott, Gillian ^a,b   Robertson, Peter W ^a   Rawlinson, William D ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Betaherpesviruses; Maternal CMV infection; Serology

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PREGNANT WOMAN; SENSITIVITY AND SPECIFICITY; SEROLOGY; SERUM;

ADULT; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CLINICAL LABORATORY TECHNIQUES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENSITIVITY AND SPECIFICITY; VIROLOGY; YOUNG ADULT;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 84871059057     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23471     Document Type: Article

References (26)

1. Baccard-Longere M, Freymuth F, Cointe D, Seigneurin JM, Grangeot-Keros L. 2001. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin Vaccine Immunol 8: 429- 431.
2. Bodéus M, Feyder S, Goubau P. 1998. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin Diagn Virol 9: 9- 16.
3. Cannon MJ, Schmid DS, Hyde TB. 2010. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20: 202- 213.
4. Curdt I, Herzogenrath J, Bernhardt S, Braun HB, Eichler R, Maine GT, Hausmann M, Pucci D, Stricker RT, Stricker RN, Lazzarotto T, Christ H. 2006. Preliminary evaluation of the Abbott ARCHITECT® Anti-Cytomegalovirus IgG*, IgM* and IgG Avidity* Assays Linked by an Automated Reflex Algorithm. American Association for Clinical Chemistry Annual Meeting. Chicago, Illinois, July 23-27.
5. Daiminger A, Bäder U, Eggers M, Lazzarotto T, Enders G. 1999. Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women. J Clin Virol 13: 161- 171.
6. Dollard SC, Grosse SD, Ross DS. 2007. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17: 355- 363.
7. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. 1992. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326: 663- 667.
8. Gerna G, Sarasini A, Patrone M, Percivalle E, Fiorina L, Campanini G, Gallina A, Baldanti F, Revello MG. 2008. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 89: 853- 865.
9. Griffiths P, Baboonian C. 1984. A prospective study of primary cytomegalovirus infection during pregnancy: Final report. BJOG 91: 307- 315.
10. Guisasola ME, Ramos B, Sanz JC, Garcia Bermejo I, De Ory M. 2010. Comparison of IgG avidity assays in the confirmation of the diagnosis of cytomegalovirus primary infection. Acta Pathol Microbiol Immunol Scand 118: 913- 991.
11. Lazzarotto T, Maine GT, Monte PD, Frush H, Shi K, Landini MP. 1996. Detection of serum immunoglobulin M to human cytomegalovirus by Western blotting correlates better with virological data than detection by conventional enzyme immunoassay. Clin Vaccine Immunol 3: 597- 600.
12. Lazzarotto T, Brojanac S, Maine GT, Landini MP. 1997. Search for cytomegalovirus-specific immunoglobulin M: Comparison between a new Western blot, conventional Western blot, and nine commercially available assays. Clin Vaccine Immunol 4: 483- 486.
13. Lazzarotto T, Ripalti A, Bergamini G, Battista MC, Spezzacatena P, Campanini F, Pradelli P, Varani S, Gabrielli L, Maine GT. 1998. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM. J Clin Microbiol 36: 3337- 3341.
14. Lazzarotto T, Varani S, Spezzacatena P, Gabrielli L, Pradelli P, Guerra B, Landini MP. 2000. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol 13: 137- 141.
15. Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP. 2008. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 41: 192- 197.
16. Mace M, Sissoeff L, Rudent A, Grangeot-Keros L. 2004. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women. Prenatal Diagn 24: 861- 863.
17. Miendje Deyi Y, Goubau P, Bodéus M. 2000. False-positive IgM antibody tests for cytomegalovirus in patients with acute Epstein-Barr virus infection. Eur J Clin Microbiol Infect Dis 19: 557- 560.
18. Mikrogen 2011. recomBlot IgG/IgM instructions for use. In: Mikrogen Diagnostik.
19. Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT, Rawlinson WD. 2005a. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 43: 4713- 4718.
20. Munro SC, Trincado D, Hall B, Rawlinson WD. 2005b. Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. J Paed Child Health 41: 449- 452.
21. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. 2006. Congenital cytomegalovirus infection following first trimester maternal infection: Symptoms at birth and outcome. J Clin Virol 35: 216- 220.
22. Rawlinson WD, Hall B, Jones C, Jeffery H, Arbuckle S, Graf N, Howard J, Morris JM. 2008. Viruses and other infections in stillbirth: What is the evidence and what should we be doing? Pathology 40: 149- 160.
23. Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G. 1998. Human cytomegalovirus in blood of immunocompetent persons during primary infection: Prognostic implications for pregnancy. J Infect Dis 177: 1170- 1175.
24. Schopfer K, Lauber E, Krech U. 1978. Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Arch Dis Childhood 53: 536- 539.
25. Sipewa M, Goubau P, Bodeus M. 2002. Evaluation of a cytomegalovirus glycoprotein B recombinant enzyme immunoassay to discriminate between a recent and a past infection. J Clin Microbiol 40: 3689- 3693.
26. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA. 1986. Primary cytomegalovirus infection in pregnancy. JAMA 256: 1904- 1908.